Hematologist
CION Cancer Clinics
When myelofibrosis turns into acute leukaemia | CION Cancer Clinics
Myelofibrosis blast phase means the disease has changed into acute myeloid leukaemia, with immature blast cells building up in the blood or marrow. It affects a minority of people and needs prompt specialist review. This page explains the signs to report, when to go to emergency, how it is confirmed, the treatment choices from intensive to comfort-focused, and who each suits. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
The short answer
What does blast phase mean in myelofibrosis?
Blast phase means myelofibrosis has changed into a form of acute myeloid leukaemia (AML), a fast-growing blood cancer. It happens in a minority of people, and it needs prompt specialist review because treatment decisions have to be made quickly.
What blasts are
Blasts are very immature blood cells. Healthy marrow keeps only a few of them, and they grow up into working red cells, white cells and platelets. In blast phase, blasts pile up in the blood or marrow without maturing. They crowd out normal blood making, so counts fall and infections and bleeding become more likely.
Accelerated phase, the step in between
Some people show a smaller rise in blasts first. This is often called accelerated phase. It is a warning that the disease is becoming more active, and it usually prompts a closer look at the treatment plan, including whether a transplant should be discussed.
Who is more likely to reach it
The risk is higher in people with higher-risk scores, certain gene changes on their marrow tests, and blasts already seen in the blood. Many people with myelofibrosis never develop blast phase. Your haematologist can tell you whether your own reports point to a higher risk.
What to watch for
What signs can suggest the disease is changing?
None of these proves blast phase on its own. Each is a reason to tell your team without waiting for the next routine review.
Changes on the blood report
Blasts appearing or rising on the blood film, or a sudden fall in haemoglobin, platelets or white cells.
Reference ranges differ between laboratories. One result is read alongside earlier reports.Infections and fevers
Fevers that keep returning, mouth sores or chest infections that are slow to clear.
Bleeding and bruising
New bruises without injury, nosebleeds, bleeding gums or tiny red spots on the skin.
Feeling suddenly worse
Symptoms that change quickly rather than over months.
For example
- Much more tiredness or breathlessness
- Bone pain
- Heavier sweats or weight loss
- A spleen that grows fast
Not sure whether this applies to you?
Ask an oncologist
!
What cannot wait
If you have myelofibrosis and develop a fever with shivering, bleeding that will not stop, black stools, confusion or severe breathlessness, go to the nearest emergency department now or call 108. Say that you have myelofibrosis and may have low blood counts, and carry your latest report. If a fever seems to settle at home, still get checked the same day, because low counts can let an infection spread quickly.
The pathway
How is blast phase confirmed and a plan made?
These steps often happen within a short time. Bring every earlier blood and marrow report, so changes can be compared rather than judged from one result.
-
A repeat blood count and blood film
A specialist looks at the cells under the microscope and counts the blasts.
-
A bone marrow test
A sample from the hip bone confirms the blast level in the marrow. Scarring can make the sample hard to draw, so a small core biopsy is often needed.
-
Flow cytometry and gene tests
These identify the type of leukaemia cells and the gene changes present, which guide treatment choices. Some are sent to specialist laboratories, so ask how long results take.
-
Fitness assessment
Heart, kidney and liver function, other illnesses and how active you are decide how intensive treatment can safely be.
-
Tumour board and family meeting
At CION, the haematology team discusses the case with other specialists, then explains the options and what each involves to you and your family.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
The choices
What treatment options are there?
Blast phase is hard to treat, and the aim differs between people. Your team will explain which of these fits your fitness, your gene results and what matters most to you.
Intensive chemotherapy
Strong treatment in hospital to clear blasts, usually as a bridge to a donor transplant. Suits only fitter people, because the side effects are heavy.
Lower-intensity treatment
Medicines such as azacitidine or decitabine, sometimes with venetoclax, given largely as day-care. Gentler, but still needs close blood count checks.
Donor transplant
The only approach that offers a chance of long-term control, done at a specialised centre, and only possible for some people once blasts are reduced.
Comfort-focused care
Palliative care, which aims at comfort and quality of life, with transfusions and infection treatment as needed. A valid choice, not giving up.
Being straight with you
What can this page not tell you?
This page cannot tell you whether blasts on one report mean blast phase, or how you will respond to treatment. Those depend on repeat tests, gene results and your fitness.
Who intensive treatment does not suit
Intensive chemotherapy and transplant are usually not suitable for people who are frail, have serious heart, lung or kidney problems, or have other illnesses that make heavy treatment too risky. For them, gentler treatment or comfort-focused care may give more good days. Choosing that path is a considered medical decision.
Having the conversation as a family
Adult children often want to protect a parent from hard news. Most people cope better when they are told clearly and kindly, and can take part in choosing. Ask the haematologist to explain the goals of each option: longer control, fewer hospital days, or comfort. Ask what happens if the first treatment does not work, and write the answers down.
Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance may cover parts of leukaemia treatment. Rules change, so check your current entitlement.Commonly believed
What do families believe about blast phase?
"Ruxolitinib caused the leukaemia."
Blast phase is part of how myelofibrosis itself can behave, and it was known long before JAK inhibitor tablets existed. Studies have not shown that these tablets cause it. Do not stop any tablet on your own; talk to your team.
"One blast on the report means it has turned into leukaemia."
A few blasts can appear in the blood in myelofibrosis without blast phase. Diagnosis rests on the level, repeat tests and often a marrow test. Ask your haematologist to explain the result.
"There is nothing that can be done now."
There are real options, from treatment aimed at transplant to gentler medicines and good comfort care. Each can ease symptoms and help with quality of life, even when long-term control is not possible.
"We should not tell her it is leukaemia."
Most people sense that something has changed. Being told clearly, with family present, lets her share in choices about hospital stays, gentler treatment and comfort. The team can help you plan how to have that conversation.
Questions we are asked
Common questions about myelofibrosis blast phase
Is blast phase the same as acute myeloid leukaemia?
Largely, yes. When blasts reach the level used to define acute leukaemia, blast-phase myelofibrosis is treated as a form of AML that grew out of an earlier blood cancer. It tends to be harder to treat than AML that appears on its own, which is why decisions are made quickly.
Can blast phase be prevented?
There is no proven way to prevent it. For fitter people in higher risk groups, a donor transplant before the disease progresses may lower the chance. Keeping regular reviews means changes in blasts or counts are found early, when more options are open.
How quickly does treatment need to start?
Usually soon after the diagnosis is confirmed, because acute leukaemia can make counts fall fast. Some tests, such as gene results, may be awaited for a short time if you are stable. If you become unwell while waiting, seek urgent care rather than waiting for the appointment.
Does CION arrange the transplant?
CION's haematology team evaluates the case, presents it at a tumour board and coordinates referral and ongoing care with qualified transplant centres. Ask which centre is suggested, what must happen before referral, and how care will be shared between the teams.
Will my father need to stay in hospital?
Intensive chemotherapy usually means a long hospital stay while counts recover. Lower-intensity treatment is mostly given as day-care, with admissions for infections or other problems. The team will explain what to expect for the option chosen.
Should he keep taking ruxolitinib?
That is a decision for his haematologist. The tablet may be continued for a time to control the spleen and symptoms, or changed as part of the new plan. Stopping it suddenly can bring symptoms back quickly, so do not stop or change it without the team.
What does palliative care offer here?
Palliative care focuses on comfort, symptom control and support for the whole family. It can run alongside active treatment, not only after it stops. It helps with pain, breathlessness, fevers, eating and difficult decisions, and it can be arranged closer to home.
Can we get a second opinion?
Yes, and it is reasonable before a major choice such as intensive treatment or transplant. Ask for copies of the blood film, marrow, flow cytometry and gene reports. Because timing matters, arrange the opinion quickly rather than letting it delay needed care.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Chronic Myeloproliferative Neoplasms Treatment (PDQ) - Patient Version
- National Cancer Institute — Adult Acute Myeloid Leukemia Treatment (PDQ) - Patient Version
- Leukemia & Lymphoma Society — Myelofibrosis
- Cancer Research UK — Acute myeloid leukaemia (AML)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Blasts on a report and worried?
Share the blood and marrow reports with us. The CION haematology team will review them quickly and explain what they mean and what comes next. One helpline serves every CION centre.